Abrams DI - Search Results

1

Nadir CD4+ T cell count predicts response to subcutaneous recombinant interleukin-2.

Markowitz N, Bebchuk JD, Abrams DI; Terry Beirn Community Program for Clinical Research on AIDS. Markowitz N, et al. Among authors: abrams di. Clin Infect Dis. 2003 Oct 15;37(8):e115-20. doi: 10.1086/378293. Epub 2003 Sep 24. Clin Infect Dis. 2003. PMID: 14523786 Clinical Trial.

2

Randomized, open-label study of the impact of two doses of subcutaneous recombinant interleukin-2 on viral burden in patients with HIV-1 infection and CD4+ cell counts of > or = 300/mm3: CPCRA 059.

Abrams DI, Bebchuk JD, Denning ET, Davey RT, Fox L, Lane HC, Sampson J, Verheggen R, Zeh D, Markowitz NP; Terry Beirn Community Programs for Clinical Research on AIDS. Abrams DI, et al. J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):221-31. doi: 10.1097/00126334-200203010-00002. J Acquir Immune Defic Syndr. 2002. PMID: 11873071 Clinical Trial.

3

Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study.

Worm SW, Bower M, Reiss P, Bonnet F, Law M, Fätkenheuer G, d'Arminio Monforte A, Abrams DI, Grulich A, Fontas E, Kirk O, Furrer H, De Wit S, Phillips A, Lundgren JD, Sabin CA; D:A:D Study Group. Worm SW, et al. Among authors: abrams di. BMC Infect Dis. 2013 Oct 9;13:471. doi: 10.1186/1471-2334-13-471. BMC Infect Dis. 2013. PMID: 24106926 Free PMC article.

4

HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies.

Monforte Ad, Abrams D, Pradier C, Weber R, Reiss P, Bonnet F, Kirk O, Law M, De Wit S, Friis-Møller N, Phillips AN, Sabin CA, Lundgren JD; Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study Group. Monforte Ad, et al. AIDS. 2008 Oct 18;22(16):2143-53. doi: 10.1097/QAD.0b013e3283112b77. AIDS. 2008. PMID: 18832878 Free PMC article.

5

Continued CD4 cell count increases in HIV-infected adults experiencing 4 years of viral suppression on antiretroviral therapy.

Hunt PW, Deeks SG, Rodriguez B, Valdez H, Shade SB, Abrams DI, Kitahata MM, Krone M, Neilands TB, Brand RJ, Lederman MM, Martin JN. Hunt PW, et al. Among authors: abrams di. AIDS. 2003 Sep 5;17(13):1907-15. doi: 10.1097/00002030-200309050-00009. AIDS. 2003. PMID: 12960823

6

CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection.

Baker JV, Peng G, Rapkin J, Abrams DI, Silverberg MJ, MacArthur RD, Cavert WP, Henry WK, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Baker JV, et al. Among authors: abrams di. AIDS. 2008 Apr 23;22(7):841-8. doi: 10.1097/QAD.0b013e3282f7cb76. AIDS. 2008. PMID: 18427202 Free PMC article.

7

HIV infection, immunodeficiency, viral replication, and the risk of cancer.

Silverberg MJ, Chao C, Leyden WA, Xu L, Horberg MA, Klein D, Towner WJ, Dubrow R, Quesenberry CP Jr, Neugebauer RS, Abrams DI. Silverberg MJ, et al. Among authors: abrams di. Cancer Epidemiol Biomarkers Prev. 2011 Dec;20(12):2551-9. doi: 10.1158/1055-9965.EPI-11-0777. Epub 2011 Nov 22. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 22109347 Free PMC article.

8

The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT.

Emery S, Abrams DI, Cooper DA, Darbyshire JH, Lane HC, Lundgren JD, Neaton JD; ESPRIT Study Group. Emery S, et al. Among authors: abrams di. Control Clin Trials. 2002 Apr;23(2):198-220. doi: 10.1016/s0197-2456(01)00179-9. Control Clin Trials. 2002. PMID: 11943448 Clinical Trial.

9

Survival of non-Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy.

Chao C, Xu L, Abrams D, Leyden W, Horberg M, Towner W, Klein D, Tang B, Silverberg M. Chao C, et al. AIDS. 2010 Jul 17;24(11):1765-70. doi: 10.1097/QAD.0b013e32833a0961. AIDS. 2010. PMID: 20453630 Free PMC article.

10

Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases.

Baker JV, Peng G, Rapkin J, Krason D, Reilly C, Cavert WP, Abrams DI, MacArthur RD, Henry K, Neaton JD; Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA). Baker JV, et al. Among authors: abrams di. J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):541-6. doi: 10.1097/QAI.0b013e31817bebb3. J Acquir Immune Defic Syndr. 2008. PMID: 18645520 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters